369 filings
6-K
BFFTF
Biofrontera AG
9 Mar 22
Biofrontera files Form 15F to suspend SEC Reporting Requirements and starts trading Level I ADS program on US OTC market
5:53pm
6-K
BFFTF
Biofrontera AG
24 Feb 22
Current report (foreign)
2:13pm
6-K
BFFTF
Biofrontera AG
22 Feb 22
Current report (foreign)
10:00am
6-K
BFFTF
Biofrontera AG
14 Feb 22
Current report (foreign)
12:00am
6-K
BFFTF
Biofrontera AG
1 Feb 22
Current report (foreign)
10:00am
6-K
pukk7zxebbnp8
13 Jan 22
Biofrontera announces preliminary revenue figures for the full year 2021
9:26am
6-K
mertjl uty
29 Dec 21
Current report (foreign)
6:20am
6-K
gck83n
14 Dec 21
Annual General Meeting
2:24pm
6-K
r4qsr112y
13 Dec 21
Current report (foreign)
10:22am
6-K
v1qweien276 c89rbo
8 Dec 21
Biofrontera AG obtains notice of allowance for US patent on PDT-lamp and treatment method
8:43am
6-K
p0bz5fzr7szn63
2 Dec 21
Biofrontera obtains notice of allowance for US patent on innovative illumination protocol
10:01am
6-K
42n ntx013hn
2 Dec 21
Biofrontera AG announces timing of the departure of the CEO
7:37am
6-K
knhby8
2 Dec 21
Current report (foreign)
12:00am
6-K
lm7gcyq
30 Nov 21
Addition to the agenda of the Annual General Meeting on 14 December 2021 pursuant to section 122 (2) AktG at the request of a shareholder
12:21pm
6-K
traicy65
29 Nov 21
Current report (foreign)
1:13pm
6-K
4ifmb7
29 Nov 21
Current report (foreign)
10:23am
6-K
pn7cj1musqqd35ut7n39
24 Nov 21
Invitation to the Annual General Meeting
10:12am
6-K
ffgp xtpoljwiw
19 Nov 21
Biofrontera AG announces mediation results
11:02am
6-K
74tyvtf0q1 c7
18 Nov 21
Quarterly report Q3 2021
12:00am
6-K
6hgpvrkgheab0lz0j
16 Nov 21
Biofrontera AG announces initiation of clinical studies
11:40am